SEC Form 4 · accession 0001225208-16-024684
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick B Verguet
Officer — CVP, Europe
Period of report
Jan 21, 2016
Accepted (ET)
Jan 25, 2016 · 4:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 21, 2016 | M | 8,000 | $15.735 | A | 107,803 | D | |
| Common StockF2 | Jan 21, 2016 | S | 8,000 | $77.00 | D | 99,803 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Acquire)F2 | $15.735 | Jan 21, 2016 | M | 8,000 | D | May 7, 2010 | May 6, 2016 | Common Stock | 8,000 | 16,000 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2015.
- F2On December 11, 2015, the common stock of Edwards Lifesciences Corporation split 2-for-1, resulting in the reporting person's ownership of additional shares of common stock and stock options. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.